跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
H-5C
首页
药物
H-5C
H-5C
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
New [F-18]-marked L-glutamic acids and L-glutamic acid derivatives (1), application thereof and method for their manufacture
申请人: BAYER SCHERING PHARMA AG
优先权: 2008
EP
2 件公开
New [F-18]-marked L-glutamic acids and L-glutamic acid derivatives (II), application thereof and method for their manufacture
申请人: BAYER SCHERING PHARMA AG
优先权: 2008
EP
2 件公开
Cosmetic composition containing a derivative of benzotriazol and an AHR antagonist
申请人: STADA ARZNEIMITTEL AG
优先权: 2008
EP
Tetrahydroquinoline derivatives
申请人: ORGANON NV
优先权: 2002
US
2 件公开
Oxidative dyeing composition for keratinic fibres containing 1-(4-aminophenyl)-pyrrolidine and an enzymatic oxidation system
申请人: OREAL
优先权: 2000
EP
Metal chelate compounds and high capacity optical recording medium using the compounds
申请人: CIBA SC HOLDING AG
优先权: 2005
EP
Method for manufacturing scopinium esters
申请人: BOEHRINGER INGELHEIM PHARMA
优先权: 2007
EP
Tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiinflammatory drugs
申请人: BAYER SCHERING PHARMA AG
优先权: 2006
EP
药物
反馈